<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">The Chinese scientific group Chenguang Shen and coworkers have collected 400 ml of convalescent plasma from patients who are recovered from SARS-CoV-2 infection and had been symptom-free for at least 10 days and transfused to five critically ill patients of SARS-CoV-2, who were under the ventilation and have ARDS. Following infusion, these patients have started to recover from day one and SARS-CoV-2 viral load was gradually decreased and the body temperatures were significantly decreased within three days. At day 9, it was reported that patients have started to take own breath without ventilation support. All the patients were symptomless, became stable and 3 out of 5 patients were discharged too [
 <xref rid="bb0650" ref-type="bibr">130</xref>]. Recently, the US-FDA allowed medical practitioners and physicians to use convalescent plasma in emergency to treat critical ill SARS-CoV-2 patients and few of the clinical studies are also initiated for the use of anti-SARS-CoV-2 and convalescent Plasma (
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04321421" id="ir0270" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04321421</ext-link>, 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04323800" id="ir0275" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04323800</ext-link>, 
 <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04325672" id="ir0280" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04325672</ext-link>) [
 <xref rid="bb0655" ref-type="bibr">131</xref>].
</p>
